A recent scientometric analysis shows a clear trend toward clinical testing of MDMA, psylocibin, ketamine and its enantiomers in treatment formats frequently associated with psychotherapy for several mental disorders ( Solmi et al., 2022 ), and psychedelic-assisted therapies might become key in addressing the most urgent mental health challenges of our time and reducing needless suffering.
1
—
—